Treatment of Peritoneal Carcinomatosis With Pressurized IntraPeritoneal Aerosol Chemotherapy -
Status:
Unknown status
Trial end date:
2020-12-01
Target enrollment:
Participant gender:
Summary
This is a study, where the efficacy of Pressurized IntraPeritoneal Aerosol Chemotherapy
(PIPAC) against peritoneal metastases will be evaluated. Furthermore, this study will focus
on the best evaluation method, where both Quality of Life questionnaires, repeated histology,
cytology and MRI will be used.